Taken together, this experiment argues that attrition of the SRF regulon in young mice does not accelerate aneurysmal disease in an experimental design that minimizes time for compensatory changes (that are driven in part by YAP/TAZ). The gene discussed is SRF; the disease is Vascular dilatation.